Efficacy and safety of three active doses of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial
2017 ◽
Vol 37
(11)
◽
pp. 1083-1091
◽
2011 ◽
Vol 84
(2)
◽
pp. 255-260
◽
2017 ◽
Vol 45
(4)
◽
pp. 418-425
◽
2018 ◽
Vol 49
◽
pp. 84-90
◽
2009 ◽
Vol 11
(7)
◽
pp. 700-708
◽
2014 ◽
Vol 64
(1)
◽
pp. 57-65
◽
2019 ◽
Vol 81
(3)
◽
pp. 411-417
◽
2015 ◽
Vol 16
(5-6)
◽
pp. 353-358
◽